肥胖与高尿酸血症、高脂血症的相关性
Relation of Obesity and Hyperuricemia, Hyperlipidemia
DOI: 10.12677/HJFNS.2019.83023, PDF,   
作者: 王馥婕, 马向华, 赵 婷, 王 瑾, 蔡金鑫:南京医科大学第一附属医院,营养科,江苏 南京;戴倩倩:徐州肿瘤医院,营养科,江苏 徐州
关键词: 肥胖高脂血症营养干预高尿酸血症Obesity Hyperlipidemia Nutritional Intervention Hyperuricemia
摘要: 目的:肥胖已逐渐成为严重的流行病,并且与心血管疾病、代谢性疾病有着密切的关系。肥胖与高脂血症、高尿酸血症之间的关系已经逐渐引起大众的关注。高尿酸血症与高血糖亦有许多共同之处,如年龄、肥胖、胰岛素抵抗等共为两者的危险因素。本研究旨在通过对肥胖人群的减重干预后,观察其人体测量指标、尿酸及血脂代谢指标等相关指标的变化,并探索其相关性,从而为临床肥胖患者的诊疗提供参考依据及新思路。方法:本研究通过对2018年3月~2019年3月南京医科大学第一附属医院营养科门诊就诊的超重/肥胖患者进行了一项前后对照的临床观察性研究,对48例10~29岁患者根据我国超重/肥胖的诊断标准(超重:体质指数BMI:24~27.9 kg/m2,肥胖BMI ≥ 28 kg/m2)筛选出目标人群,予以为期2个月的饮食干预及抗阻力运动指导,观察干预前后人体测量指标,如体重、脂肪量、骨骼肌量、腰围及臀围、BMI等、以及尿酸、血脂指标(总胆固醇TC、甘油三酯TG、低密度脂蛋白胆固醇LDL、高密度脂蛋白胆固醇HDL-C)、糖化血红蛋白(HbAIC)的变化并分析体测指标与尿酸、血脂代谢指标之间的相关性。结果:本研究筛选48例门诊患者中,皆符合超重/肥胖的诊断标准,并愿配合进行肥胖相关指标的检查,并符合其诊断。其中男:女 = 25:23,平均年龄17.58 ± 4.82岁,最终完成研究的共30人,(因故中途脱组/退出18人),配合完成本研究检测项目的共9人。干预56 ± 7天后,体重、腰围及臀围等人体测量指标有明显的下降;尿酸亦有明显下降;血脂指标(总胆固醇、甘油三酯、低密度脂蛋白胆固醇)均有明显改善、糖化血红蛋白降低。相关性分析:体重与尿酸(P = 0.031, r = −0.510)、骨骼肌与尿酸(P = 0.046, r = 0.477)、腰围与尿酸(P = 0.045, r = −0.478)存在相关;高脂血症与高尿酸血症之间存在着一定的联系。结论:肥胖患者通过营养干预及运动指导后,人体测量指标、尿酸、血脂代谢指标均有一定的变化;体测指标与尿酸之间具有一定的相关性,因此进一步探索尿酸、血脂代谢等在肥胖发生发展中的影响及作用机制,对早期干预及治疗超重及肥胖人群有一定的启发指导意义。
Abstract: Objective: Obesity has gradually become a serious epidemic disease and it is closely related to cardiovascular diseases and metabolic diseases. The relationship between obesity and Hyperlipidemia, Hyperuricemia has gradually attracted public attention. Hyperuricemia and Hyperglycemia have many common factors, such as age, obesity, insulin resistance and others which are the risk factors of both. The purpose of this study is to observe the changes of anthropometric indexes, uric acid and lipid metabolism indexes of obesity after weight reduction intervention, and explore their correlation, so as to provide a reference basis and new ideas for clinical diagnosis and treatment of obesity. Methods: This study conducted a pre- and post-control clinical observational study on the overweight/obesity in the outpatient department of Nutrition Department of the First Affiliated Hospital of Nanjing Medical University from March 2018 to March 2019. According to the diagnostic criteria of overweight/obesity in China (Overweight: BMI: 24 - 27.9 kg/m2, Obesity BMI >28 kg/m2), 48 patients (age: 10 - 29) were selected for diet intervention and resistance exercise in two months to observe the changes of anthropometric indexes such as body weight, fat mass, skeletal muscle mass, waist circumference and hip circumference, BMI, uric acid, blood lipid index (Total Cholesterol, Triglyceride, Low Density Lipoprotein, High density liptein cholesterol), HbAIC, and the correlation between the indexes of anthropometric measurement and uric acid, blood lipid metabolism index was analyzed. Results: In this study, 48 patients were selected; all of them met the diagnostic criteria of overweight/obesity, and were willing to cooperate with the examination of obesity-related indicators and accord with their diagnosis. Among them, male:female is 25:23, with an average age of 17.58 ± 4.82. A total of 30 people completed the study (18 out of group/out of group) and 9 people cooperated with the completion of the test project. After 56 ± 7 days of intervention, body weight, waist circumference, hip circumference and other anthropometric indicators decreased significantly; uric acid also decreased significantly; blood lipid indicators (TC, TG, LDL) were significantly improved, and HbAIC decreased. Relevance analysis: Body weight was correlated with uric acid (P = 0.031, r = −0.510), skeletal muscle with uric acid (P = 0.046, r = 0.477), and waist circumference with uric acid (P = 0.045, r = −0.478). There is a relationship between Hyperlipidemia and Hyperuricemia. Conclusion: After nutritional intervention and exercise guidance, the indexes of anthropometry, uric acid and blood lipid metabolism of obesity have changed; there is a certain correlation between the indexes of body measurement and uric acid, so further exploring the influence and mechanism of uric acid and blood lipid metabolism on the occurrence and development of obesity can provide some inspiration and guidance for early intervention and treatment of overweight and obesity.
文章引用:王馥婕, 马向华, 赵婷, 王瑾, 蔡金鑫, 戴倩倩. 肥胖与高尿酸血症、高脂血症的相关性[J]. 食品与营养科学, 2019, 8(3): 180-186. https://doi.org/10.12677/HJFNS.2019.83023

参考文献

[1] 唐永忠, 王萍, 等. 肥胖与高血压、高脂血症、高血糖的相关性[J]. 海南医学, 2008, 19(11): 56-57.
[2] 刘倩, 刘维英, 等. 学龄期肥胖儿童血尿酸水平及相关因素分析[J]. 临床儿科杂志, 2013, 31(9): 842-844.
[3] 罗浩, 张瑞林. 肥胖与高尿酸血症的关系[J]. 检验医学与临床, 2010, 7(5): 457-457.
[4] 王琨, 李淑元, 等. 4种肥胖测量指标与高脂血症关系的比较研究及适宜切点的选择[J]. 复旦学报, 2015, 42(3): 332-337.
[5] 季成叶, 中国肥胖问题工作组. 中国学龄儿童青少年超重, 肥胖筛查体质量指数值分类标准[J]. 中华流行病学杂志, 2004, 25(2): 97-102.
[6] Tamba, S., Nishizawa, H., Funahashi, T., et al. (2008) Relationship between the Serum Uric Acid Level, Visceral Fat Accumulation and Serum Adiponectin Concentration in Japanese Men. Internal Medicine, 47, 1175-1180. [Google Scholar] [CrossRef] [PubMed]
[7] 王春雨, 万东君, 姜一真, 等. 高尿酸血症与2型糖尿病的关系探讨[J]. 医学与哲学, 2010, 31(14): 49-50.
[8] 中国医师协会心血管内科医师分会, 中国医师协会循证医学专业委员会. 无症状高尿酸血症合并心血管疾病诊治建议中国专家共识[J]. 中国全科医学, 2010, 13(11): 1145-1149.
[9] 中华医学会内分泌学分会肥胖学组. 中国成人肥胖症防治专家共识[J]. 中华内分泌代谢杂志, 2011, 27(9): 711.
[10] Jensen, M.D., Ryan, D.H., Apovian, C.M., et al. (2013) AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity. Circulation, 129, S102-S138. [Google Scholar] [CrossRef] [PubMed]
[11] 许小花, 董关萍, 等. 肥胖儿童血尿酸联合年龄、腰围、体质量指数预测代谢综合征的价值[J]. 中华实用儿科临床杂志, 2017, 32(8): 585-590.
[12] 尹雪瑶, 周嘉强, 等. 尿酸与腹型肥胖及代谢综合征相关性研究[J]. 中华内科杂志, 2014, 53(1): 13-18.
[13] Andersen, C.J. and Fernandez, M.L. (2013) Dietary Strategies to Reduce Metabolic Syndrome. Reviews in Endocrine and Metabolic Disorders, 14, 241-254. [Google Scholar] [CrossRef] [PubMed]
[14] 岳少杰, 王铭杰. 母孕期肥胖对胎儿–新生儿的影响及管理[J]. 中国小儿急救医学, 2016, 23(5): 295-299.
[15] 丁世彬, 张国富, 等. 环境内分泌干扰物与代谢综合征[J]. 新乡医学院学报, 2015, 32(2): 101-106.
[16] 王洪莎, 郭蔚莹, 等. 高尿酸血症与高血糖、高血压及肥胖的关系[J]. 中国老年学杂志, 2016, 22(36): 5729-5732.
[17] Waring, W.S., Webb, D.J. and Maxwell, S.R. (2001) Systemic Uric Acid Administration Increase Serum Antionxidant Capacity in Healthy Volunteers. Journal of Cardiovascular Pharmacology, 38, 365-371. [Google Scholar] [CrossRef] [PubMed]
[18] So, A. and Thorens, B. (2010) Uric Acid Transport and Disease. Journal of Clinical Investigation, 120, 1791-1799. [Google Scholar] [CrossRef
[19] 赵思文, 等. 高尿酸血症与代谢综合征相关因素分析[J]. 天津医药, 2012, 27(7): 614-617.
[20] 苗志敏, 李长贵, 等. 高尿酸血症防治中应关注的几个关键问题[J]. 中华内分泌代谢杂志, 2011, 27(7): 543-547.